Invention Grant
US08426571B2 Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
失效
核酸和相应的蛋白质，名称为202P5A5，可用于治疗和检测癌症
- Patent Title: Nucleic acids and corresponding proteins entitled 202P5A5 useful in treatment and detection of cancer
- Patent Title (中): 核酸和相应的蛋白质，名称为202P5A5，可用于治疗和检测癌症
-
Application No.: US13021202Application Date: 2011-02-04
-
Publication No.: US08426571B2Publication Date: 2013-04-23
- Inventor: Arthur B. Raitano , Mary Faris , Pia M. Challita-Eid , Aya Jakobovits , Wangmao Ge
- Applicant: Arthur B. Raitano , Mary Faris , Pia M. Challita-Eid , Aya Jakobovits , Wangmao Ge
- Applicant Address: US CA Santa Monica
- Assignee: Agensys, Inc.
- Current Assignee: Agensys, Inc.
- Current Assignee Address: US CA Santa Monica
- Agency: Morrison & Foerster LLP
- Main IPC: C07H21/02
- IPC: C07H21/02 ; C12N15/00 ; C12N1/20 ; C12P21/06
Abstract:
A novel gene 202P5A5 and its encoded protein, and variants thereof, are described wherein 202P5A5 exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers listed in Table I. Consequently, 202P5A5 provides a diagnostic, prognostic, prophylactic and/or therapeutic target for cancer. The 202P5A5 gene or fragment thereof, or its encoded protein, or variants thereof, or a fragment thereof, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 202P5A5 can be used in active or passive immunization.
Public/Granted literature
- US20110201052A1 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 202P5A5 USEFUL IN TREATMENT AND DETECTION OF CANCER Public/Granted day:2011-08-18
Information query
